Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1977 Sep;60(3):626–638. doi: 10.1172/JCI108814

Phytohemagglutinin Response in Systemic Lupus Erythematosus

RECONSTITUTION EXPERIMENTS USING HIGHLY PURIFIED LYMPHOCYTE SUBPOPULATIONS AND MONOCYTES

Peter D Utsinger 1, William J Yount 1
PMCID: PMC372407  PMID: 330565

Abstract

The phytohemagglutinin (PHA) response of lymphocytes from untreated patients with systemic lupus erythematosus (SLE) was studied using highly purified subpopulations of cells involved in the transformation response: T lymphocytes, B lymphocytes, and monocytes. Cell transformation was quantitated using both tritiated thymidine ([3H]-TdR) incorporation into DNA and cytofluorographic determination of cellular DNA content. Dose-response curves using six concentrations of PHA and five concentrations of cells over 0-5 days revealed a decrease in [3H]TdR by stimulated lymphocytes from some SLE patients. This decrease in [3H]TdR was paralleled by a decreased percentage of cells in S, G2, and M phases of the cell cycle. However, abnormal response occurred entirely in those SLE patients who were hypocomplementemic. The etiology of the impaired response was further examined. Lymphocyte receptors for concanavalin A were studied using cytofluorography of lymphocytes stained with fluorescein-conjugated concanavalin A. The frequency distribution of concanavalin A receptors was similar in the normocomplementemic and hypocomplementemic lupus patients and in normals. The latex phagocytic activity of lupus macrophages was similar to normals when allogeneic normal plasma was used in the culture medium. Phagocytic activity became abnormal in the presence of SLE plasma. However, there was no difference in the [3H]TdR response or the percentage of cells in S, G2, and M phases when T lymphocytes from the hypocomplementemic patients were stimulated on either autologous or normal allogeneic monocyte monolayers. Likewise, normal lymphocytes incorporated similar amounts of [3H]TdR and had similar percentages of cells in S, G2, and M phases whether their T lymphocytes were stimulated on autologous or SLE monocyte monolayers. Highly purified subpopulations of B and T lymphocytes were obtained by density sedimentation or Fenwal Leuko-Pak passage of lymphocyte populations. The response to PHA by lymphocytes from the hypocomplementemic lupus patients could be seen to involve at least two abnormalities. One, in reference to normal lymphocytes, SLE T lymphocytes plus monocytes had an impaired response; two, SLE B lymphocytes plus SLE T lymphocytes plus SLE monocytes had an impaired response. Two patients in the hypocomplementemic group were treated with steroids. 5 days after steroid treatment was initiated, the percentage of cells in S, G2, and M phases and the [3H]TdR response of PHA-stimulated lymphocytes returned to normal. The normalization of the [3H]TdR response was explained both by a return of purified T cells plus monocytes, purified B cells plus monocytes, and whole lymphocyte populations to normal responsiveness. These studies suggest that a steroid-correctable defect exists in T and B lymphocytes in SLE.

Full text

PDF
626

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASKONAS B. A., RHODES J. M. IMMUNOGENICITY OF ANTIGEN-CONTAINING RIBONUCLEIC ACID PREPARATIONS FROM MACROPHAGES. Nature. 1965 Jan 30;205:470–474. doi: 10.1038/205470a0. [DOI] [PubMed] [Google Scholar]
  2. Adams R. L. The effect of endogenous pools of thymidylate on the apparent rate of DNA synthesis. Exp Cell Res. 1969 Jul;56(1):55–58. doi: 10.1016/0014-4827(69)90393-0. [DOI] [PubMed] [Google Scholar]
  3. Block S. R., Gibbs C. B., Stevens M. B., Shulman L. E. Delayed hypersensitivity in systemic lupus erythematosus. Ann Rheum Dis. 1968 Jul;27(4):311–318. doi: 10.1136/ard.27.4.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Crout J. E., Hepburn B., Ritts R. E., Jr Suppression of lymphocyte transformation after aspirin ingestion. N Engl J Med. 1975 Jan 30;292(5):221–223. doi: 10.1056/NEJM197501302920501. [DOI] [PubMed] [Google Scholar]
  5. Delbarre F., Pompidou A., Kahan A., Brouilhet H., Le Gô A., Amor B. Etude des lymphocytes du sang au cours de la maladie lupique. Pathol Biol (Paris) 1971 Apr;19(7):379–387. [PubMed] [Google Scholar]
  6. Delespesse G., Duchateau J., Gausset P., Govaerts A. In vitro response of subpopulations of human tonsil lymphocytes. I. Cellular collaboration in the proliferative response to PHA and Con A. J Immunol. 1976 Feb;116(2):437–445. [PubMed] [Google Scholar]
  7. Dickler H. B. Studies of the human lymphocyte receptor for heat-aggregated or antigen-complexed immunoglobulin. J Exp Med. 1974 Aug 1;140(2):508–522. doi: 10.1084/jem.140.2.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dixon R., Rosse W., Ebbert L. Quantitative determination of antibody in idiopathic thrombocytopenic purpura. Correlation of serum and platelet-bound antibody with clinical response. N Engl J Med. 1975 Jan 30;292(5):230–236. doi: 10.1056/NEJM197501302920503. [DOI] [PubMed] [Google Scholar]
  9. Greaves M. F., Brown G. Purification of human T and B lymphocytes. J Immunol. 1974 Jan;112(1):420–423. [PubMed] [Google Scholar]
  10. Hahn B. H., Bagby K. K., Osterland C. K. Abnormalities of delayed hypersensitivity in systemic lupus erythematosus. Am J Med. 1973 Jul;55(1):25–31. doi: 10.1016/0002-9343(73)90146-0. [DOI] [PubMed] [Google Scholar]
  11. Horwitz D. A., Cousar J. B. A relationship between impaired cellular immunity humoral suppression of lymphocyte function and severity of systemic lupus erythematosus. Am J Med. 1975 Jun;58(6):829–835. doi: 10.1016/0002-9343(75)90639-7. [DOI] [PubMed] [Google Scholar]
  12. Horwitz D. A. Impaired delayed hypersensitivity in systemic lupus erythematosus. Arthritis Rheum. 1972 Jul-Aug;15(4):353–359. doi: 10.1002/art.1780150406. [DOI] [PubMed] [Google Scholar]
  13. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  14. KUNKEL H. G., TAN E. M. AUTOANTIBODIES AND DISEASE. Adv Immunol. 1964;27:351–395. doi: 10.1016/s0065-2776(08)60711-7. [DOI] [PubMed] [Google Scholar]
  15. Koffler D., Carr R., Agnello V., Thoburn R., Kunkel H. G. Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease. J Exp Med. 1971 Jul 1;134(1):294–312. doi: 10.1084/jem.134.1.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kraemer P. M., Tobey R. A., Van Dilla M. A. Flow microfluorometric studies of lectin binding to mammalian cells. I. General features. J Cell Physiol. 1973 Jun;81(3):305–314. doi: 10.1002/jcp.1040810303. [DOI] [PubMed] [Google Scholar]
  17. Krikorian G., Marshall W. H., Simmons S., Stratton F. Counts and characteristics of macrophage precursors in human peripheral blood. Cell Immunol. 1975 Sep;19(1):22–31. doi: 10.1016/0008-8749(75)90288-9. [DOI] [PubMed] [Google Scholar]
  18. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  19. Lipsky P. E., Rosenthal A. S. Macrophage-lymphocyte interaction: antigen-independent binding of guinea pig lymph node lymphocytes by macrophages. J Immunol. 1975 Aug;115(2):440–445. [PubMed] [Google Scholar]
  20. Lockshin M. D., Eisenhauer A. C., Kohn R., Weksler M., Block S., Mushlin S. B. Cell-mediated immunity in rheumatic diseases. II. Mitogen responses in RA, SLE, and other illnesses: correlation with T- and B-lymphocyte populations. Arthritis Rheum. 1975 May-Jun;18(3):245–250. doi: 10.1002/art.1780180308. [DOI] [PubMed] [Google Scholar]
  21. Malavé I., Layrisse Z., Layrisse M. Dose-dependent hyporreactivity to phytohemagglutinin in systemic lupus erythematosus. Cell Immunol. 1975 Feb;15(2):231–236. doi: 10.1016/0008-8749(75)90001-5. [DOI] [PubMed] [Google Scholar]
  22. Messner R. P. Clinical aspects of T- and B-lymphocytes in rheumatic diseases. Arthritis Rheum. 1974 Jul-Aug;17(4):339–346. doi: 10.1002/art.1780170402. [DOI] [PubMed] [Google Scholar]
  23. Parish C. R., Hayward J. A. The lymphocyte surface. II. Separation of Fc receptor, C'3 receptor and surface immunoglobulin-bearing lymphocytes. Proc R Soc Lond B Biol Sci. 1974 Aug 27;187(1086):65–81. doi: 10.1098/rspb.1974.0061. [DOI] [PubMed] [Google Scholar]
  24. Paty J. G., Jr, Sienknecht C. W., Townes A. S., Hanissian A. S., Miller J. B., Masi A. T. Impaired cell-mediated immunity in systemic lupus erythematosus (SLE). A controlled study of 23 untreated patients. Am J Med. 1975 Dec;59(6):769–779. doi: 10.1016/0002-9343(75)90462-3. [DOI] [PubMed] [Google Scholar]
  25. Rosenstreich D. L., Farrar J. J., Dougherty S. Absolute macrophage dependency of T lymphocyte activation by mitogens. J Immunol. 1976 Jan;116(1):131–139. [PubMed] [Google Scholar]
  26. Rosenthal C. J., Franklin E. C. Depression of cellular-mediated immunity in systemic lupus erythematosus. relation to disease activity. Arthritis Rheum. 1975 May-Jun;18(3):207–217. doi: 10.1002/art.1780180303. [DOI] [PubMed] [Google Scholar]
  27. Ross G. D., Rabellino E. M., Polley M. J., Grey H. M. Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes. J Clin Invest. 1973 Feb;52(2):377–385. doi: 10.1172/JCI107194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Scheinberg M. A., Cathcart E. S. B cell and T cell lymphopenia in systemic lupus erythematosus. Cell Immunol. 1974 May;12(2):309–314. doi: 10.1016/0008-8749(74)90083-5. [DOI] [PubMed] [Google Scholar]
  29. Smets L. A. Discrepancies between precursor uptake and DNA synthesis in mammalian cells. J Cell Physiol. 1969 Aug;74(1):63–66. doi: 10.1002/jcp.1040740109. [DOI] [PubMed] [Google Scholar]
  30. Stobo J. D., Talal N., Paul W. E. Lymphocyte classes in New Zealand mice. I. Ontogeny and mitogen responsiveness of thymocytes and thymus-derived lymphocytes. J Immunol. 1972 Oct;109(4):692–700. [PubMed] [Google Scholar]
  31. Suciu-Foca N., Buda J. A., Thiem T., Reemtsma K. Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus. Clin Exp Immunol. 1974 Nov;18(3):295–301. [PMC free article] [PubMed] [Google Scholar]
  32. TERASAKI P. I., MCCLELLAND J. D. MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS. Nature. 1964 Dec 5;204:998–1000. doi: 10.1038/204998b0. [DOI] [PubMed] [Google Scholar]
  33. Terasaki P. I., Mottironi V. D., Barnett E. V. Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med. 1970 Oct 1;283(14):724–728. doi: 10.1056/NEJM197010012831403. [DOI] [PubMed] [Google Scholar]
  34. Utsinger P. D. Impaired T-cell transformation in chronic lymphocytic leukemia (CLL): Demonstration of a blastogenesis inhibitory factor. Blood. 1975 Dec;46(6):883–890. [PubMed] [Google Scholar]
  35. Utsinger P. D. Lymphocyte responsiveness in systemic lupus erythematosus. Arthritis Rheum. 1976 Jan-Feb;19(1):88–92. doi: 10.1002/art.1780190115. [DOI] [PubMed] [Google Scholar]
  36. Utsinger P. D. Relationship of lymphocytotoxic antibodies to lymphopenia and parameters of disease activity in systemic lupus erythematosus. J Rheumatol. 1976 Jun;3(2):175–185. [PubMed] [Google Scholar]
  37. Van Dilla M. A., Trujillo T. T., Mullaney P. F., Coulter J. R. Cell microfluorometry: a method for rapid fluorescence measurement. Science. 1969 Mar 14;163(3872):1213–1214. doi: 10.1126/science.163.3872.1213. [DOI] [PubMed] [Google Scholar]
  38. Winchester R. J., Fu S. M., Hoffman T., Kunkel H. G. IgG on lymphocyte surfaces; technical problems and the significance of a third cell population. J Immunol. 1975 Apr;114(4):1210–1212. [PubMed] [Google Scholar]
  39. Winfield J. B., Winchester R. J., Kunkel H. G. Association of cold-reactive antilymphocyte antibodies with lymphopenia in systemic lupus erythematosus. Arthritis Rheum. 1975 Nov-Dec;18(6):587–594. doi: 10.1002/art.1780180609. [DOI] [PubMed] [Google Scholar]
  40. Yahara I., Edelman G. M. Restriction of the mobility of lymphocyte immunoglobulin receptors by concanavalin A. Proc Natl Acad Sci U S A. 1972 Mar;69(3):608–612. doi: 10.1073/pnas.69.3.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Yam L. T., Li C. Y., Crosby W. H. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol. 1971 Mar;55(3):283–290. doi: 10.1093/ajcp/55.3.283. [DOI] [PubMed] [Google Scholar]
  42. Zeman G. O., Cohen G., Budrys M., Williams G. C., Javor H. The effect of plasma cortisol levels on the lymphocyte transformation test. J Allergy Clin Immunol. 1972 Jan;49(1):10–15. doi: 10.1016/0091-6749(72)90118-2. [DOI] [PubMed] [Google Scholar]
  43. Zucker-Franklin D. The percentage of monocytes among "mononuclear" cell fractions obtained from normal human blood. J Immunol. 1974 Jan;112(1):234–240. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES